ACM Research, Inc.
50.55USD
+1.4300 (+2.91%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ACMR.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.52▲ | $0.47 | 1 | 2 |
| Next quarter | $0.54▲ | $0.51 | 2 | 1 |
| Current year | $2.14▲ | $1.68 | 3 | 0 |
| Next year | $2.94▲ | $2.25 | 3 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.34 | $0.61 | +0.27 (+81.2%) |
| 2026-03-31 | $0.2 | $0.34 | +0.14 (+72.9%) |
| 2025-12-31 | $0.4 | $0.25 | -0.15 (-37.5%) |
| 2025-09-30 | $0.53 | $0.36 | -0.17 (-32.4%) |
66 ratings from 12 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Daiwa Capital | Initiated | Buy | $136 | Aug 26, 2026 |
| Morgan Stanley | Maintained | Overweight | $90 $130 | Jun 24, 2026 |
| Roth Capital | Maintained | Buy | $100 $125 | Jun 18, 2026 |
| Seaport Global | Initiated | Buy | $75 | May 5, 2026 |
| Roth Capital | Maintained | Buy | $40 $50 | Sep 30, 2025 |
| JP Morgan | Initiated | Overweight | $36 | Feb 28, 2025 |
| Needham | Reiterated | Hold | — | Feb 27, 2025 |
| Craig-Hallum | Downgraded from Buy | Hold | $30 $18 | Dec 5, 2024 |
| Needham | Downgraded from Buy | Hold | $25 | Dec 4, 2024 |
| Needham | Reiterated | Buy | $25 | Oct 1, 2024 |
| Benchmark | Reiterated | Buy | $38 | Aug 8, 2024 |
| Roth MKM | Maintained | Buy | $40 $30 | Aug 8, 2024 |
| Needham | Reiterated | Buy | $28 | Aug 8, 2024 |
| Benchmark | Reiterated | Buy | $38 | Aug 7, 2024 |
| Needham | Reiterated | Buy | $34 | May 9, 2024 |
| Benchmark | Maintained | Buy | $35 $38 | Mar 6, 2024 |
| Goldman Sachs | Upgraded from Neutral | Buy | $39 | Feb 29, 2024 |
| Benchmark | Maintained | Buy | $32 $35 | Feb 29, 2024 |
| Needham | Maintained | Buy | $24 $34 | Feb 28, 2024 |
| Goldman Sachs | Maintained | Neutral | $19.5 $22.1 | Jan 11, 2024 |
| Roth MKM | Maintained | Buy | $20 $25 | Jan 10, 2024 |
| Needham | Maintained | Buy | $18 $24 | Jan 10, 2024 |
| Benchmark | Reiterated | Buy | $32 | Nov 8, 2023 |
| Goldman Sachs | Maintained | Neutral | $16.2 $18.2 | Oct 12, 2023 |
| Goldman Sachs | Maintained | Neutral | $14.2 $16.2 | Sep 1, 2023 |
83 filings from 12 insiders · 6 buy / 6 sell over 6m
Officers and directors of ACMR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| WANG DAVID HUIOfficer, Director and Beneficial Owner | Exercise | 140.0k | $1.00 | $140k | Sep 9, 2026 |
| WANG DAVID HUIOfficer, Director and Beneficial Owner | Sell | 140.0k | $73.80 | $10.63M | Sep 9, 2026 |
| MCKECHNIE MARK AChief Financial Officer | Exercise | 55.2k | $13.89 | $936k | Aug 20, 2026 |
| MCKECHNIE MARK AChief Financial Officer | Sell | 55.2k | $76.34 | $4.26M | Aug 20, 2026 |
| DUN HAIPINGDirector | Exercise | 5.0k | $5.60 | $28k | Aug 18, 2026 |
| DUN HAIPINGDirector | Sell | 5.0k | $80.29 | $406k | Aug 18, 2026 |
| CHEAV SOTHEARAOfficer | Exercise | 18.8k | $13.89 | $260k | Jun 5, 2026 |
| CHEAV SOTHEARAOfficer | Sell | 18.8k | $81.73 | $1.59M | Jun 5, 2026 |
| WANG DAVID HUIChief Executive Officer | Exercise | 100.0k | $1.00 | $100k | Jun 4, 2026 |
| WANG DAVID HUIChief Executive Officer | Sell | 100.0k | $83.86 | $8.84M | Jun 4, 2026 |
| DUN HAIPINGDirector | Exercise | 5.0k | $5.60 | $28k | May 19, 2026 |
| DUN HAIPINGDirector | Sell | 5.0k | $63.84 | $331k | May 19, 2026 |
| PAPPIS CHARLES CDirector | Exercise | 5.0k | $29.18 | $146k | Apr 17, 2026 |
| PAPPIS CHARLES CDirector | Sell | 5.0k | $52.00 | $260k | Apr 17, 2026 |
| MCKECHNIE MARK AChief Financial Officer | Exercise | 98.6k | $13.89 | $1.58M | Mar 12, 2026 |
| WANG DAVID HUIChief Executive Officer | Exercise | 110.0k | $1.00 | $110k | Mar 12, 2026 |
| MCKECHNIE MARK AChief Financial Officer | Sell | 98.6k | $44.89 | $4.49M | Mar 12, 2026 |
| WANG DAVID HUIChief Executive Officer | Sell | 110.0k | $44.92 | $5.15M | Mar 12, 2026 |
| LIU TRACY DONGDirector | Exercise | 60.0k | $1.00 | $60k | Mar 11, 2026 |
| LIU TRACY DONGDirector | Sell | 60.0k | $47.06 | $2.85M | Mar 11, 2026 |
No analyst notes on ACMR yet.
Analyst Ratings
9 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 6 | 1 | 0 | 0 | Buy1.80 |
| 1 mo ago | 2 | 6 | 1 | 0 | 0 | Buy1.89 |
| 2 mo ago | 2 | 6 | 1 | 0 | 0 | Buy1.89 |
| 3 mo ago | 2 | 5 | 1 | 0 | 0 | Buy1.88 |
Members whose judged calls on ACMR have played out most reliably.
No settled calls on ACMR yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice